Co-prevalence of Epstein–Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 7, 2016, Pages 1936-1939

  Al Moustafa, Ala Eddin ^a,b,c   Al Antary, Noor ^a   Aboulkassim, Tahar ^d   Akil, Nizar ^c,e,f   Batist, Gerald ^b,d   Yasmeen, Amber ^d  

^a QATAR UNIVERSITY   (Qatar)

^b MCGILL UNIVERSITY   (Canada)

^c Syrian Research Cancer Centre of the Syrian Society against Cancer   (Syrian Arab Republic)

^d MCGILL UNIVERSITY   (Canada)

^e GAZIANTEP UNIVERSITY   (Turkey)

^f UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

Author keywords

breast cancer; cancer phenotype; EBV; high risk HPV; Syrian women

Indexed keywords

INHIBITOR OF DIFFERENTIATION 1;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CARCINOGENESIS; EPITHELIAL MESENCHYMAL TRANSITION; EPSTEIN BARR VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SYRIAN ARAB REPUBLIC; WART VIRUS; BREAST TUMOR; CLASSIFICATION; COMPLICATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; ISOLATION AND PURIFICATION; PAGET NIPPLE DISEASE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SYRIA;

EID: 84963859135     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2016.1139255     Document Type: Article

References (23)

1. A.Saha, R.Kaul, M.Murakami, E.S.Robertson. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Cancer Biol Ther 2010; 10:961-78; PMID:21084867; http://dx.doi.org/10.4161/cbt.10.10.13923
2. A.-E.Al Moustafa. Role of high-risk human papillomaviruses in breast carcinogenesis. In: S.P.Gupta, editor. Breast Carcinogenesis; Oncoviruses and Their Inhibitors, Boca Raton: CRC, Taylor and Francis Group 2014. p. 245-62.
3. T.Aboulkassim, A.Yasmeen, N.Akil, G.Batist, A.E.Al Moustafa. Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study. Hum Vaccin Immunother 2015;11:951-5; PMID:25933186; http://dx.doi.org/10.1080/21645515.2015.1009342
4. A.Kalkan, A.Ozdarendeli, Y.Bulut, H.Yekeler, B.Cobanoglu, M.Z.Doymaz. Investigation of Epstein-Barr virus DNA in formalin-fixed and paraffin- embedded breast cancer tissues. Med Princ Pract 2005; 14:268-71; PMID:15961939; http://dx.doi.org/10.1159/000085748
5. M.A.Lorenzetti, E.De Matteo, H.Gass, P.Martinez Vazquez, J.Lara, P.Gonzalez, M.V.Preciado, P.A.Chabay. Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma. PLoS One 2010; 5:e13603; PMID:21042577; http://dx.doi.org/10.1371/journal.pone.0013603
6. M.Hachana, K.Amara, S.Ziadi, E.Romdhane, R.B.Gacem, M.Trimeche. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia. Pathol Res Pract 2011; 207:695-700; PMID:22024152; http://dx.doi.org/10.1016/j.prp.2011.09.007
7. W.K.Glenn, B.Heng, W.Delprado, B.Iacopetta, N.J.Whitaker, J.S.Lawson. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One 2012; 7:e48788; PMID:23183846; http://dx.doi.org/10.1371/journal.pone.0048788
8. A.R.Zekri, A.A.Bahnassy, W.S.Mohamed, F.A.El-Kassem, S.J.El-Khalidi, M.M.Hafez, Z.K.Hassan. Epstein-Barr virus and breast cancer: epidemiological and molecular study on Egyptian and Iraqi women. J Egypt Natl Canc Inst 2012; 24:123-31; PMID:22929918; http://dx.doi.org/10.1016/j.jnci.2012.06.001
9. T.Horikawa, T.Yoshizaki, S.Kondo, M.Furukawa, Y.Kaizaki, J.S.Pagano. Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer 2011; 104:1160-7; PMID:21386845; http://dx.doi.org/10.1038/bjc.2011.38
10. L.Wang, W.D.Tian, X.Xu, B.Nie, J.Lu, X.Liu, Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. Cancer 2014; 120:363-72; PMID:24190575; http://dx.doi.org/10.1002/cncr.28418
11. A.Yasmeen, T.A.Bismar, M.Kandouz, W.D.Foulkes, P.Y.Desprez, A.E.Al Moustafa. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle 2007; 6:2038-42; PMID:17721085; http://dx.doi.org/10.4161/cc.6.16.4555
12. M.T.Ling, X.Wang, X.Zhang, Y.C.Wong. The multiple roles of Id-1 in cancer progression. Differentiation 2006; 74:481-7; PMID:17177845; http://dx.doi.org/10.1111/j.1432-0436.2006.00083.x
13. N.Akil, A.Yasmeen, A.Kassab, L.Ghabreau, A.D.Darnel, A.E.Al Moustafa.High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer 2008; 99:404-7; PMID:18648363; http://dx.doi.org/10.1038/sj.bjc.6604503
14. A.E.Al Moustafa, R.Al-Awadhi, N.Missaoui, I.Adam, R.Durusoy, L.Ghabreau, N.Akil, H.G.Ahmed, A.Yasmeen, G.Alsbeih. Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions. Hum Vaccin Immunother 2014; 10:1812-21; PMID:25424787; http://dx.doi.org/10.4161/hv.28742
15. P.de Cremoux, M.Thioux, I.Lebigot, B.Sigal-Zafrani, R.Salmon, X.Sastre-Garau, Institut Curie Breast Group. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 2008; 109:55-8; PMID:17624590; http://dx.doi.org/10.1007/s10549-007-9626-4
16. S.Hedau, U.Kumar, S.Hussain, S.Shukla, S.Pande, N.Jain, A.Tyagi, T.Deshpande, D.Bhat, M.M.Mir, et al. Breast cancer and human papillomavirus infection: no evidence of HPV etiology of breast cancer in Indian women. BMC Cancer 2011; 11:27; PMID:21247504; http://dx.doi.org/10.1186/1471-2407-11-27
17. F.Aguayo, N.Khan, C.Koriyama, C.González, S.Ampuero, O.Padilla, L.Solís, Y.Eizuru, A.Corvalán, S.Akiba. Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile. Infect Agent Cancer 2011; 6:7; PMID:21699721; http://dx.doi.org/10.1186/1750-9378-6-7
18. J.Peng, T.Wang, H.Zhu, J.Guo, K.Li, Q.Yao, Y.Lv, J.Zhang, C.He, J.Chen, et al. Multiplex PCR/mass spectrometry screening of biological carcinogenic agents in human mammary tumors. J Clin Virol 2014; 61:255-9; PMID:25088618; http://dx.doi.org/10.1016/j.jcv.2014.07.010
19. J.H.Tsai, C.H.Tsai, M.H.Cheng, S.J.Lin, F.L.Xu, C.C.Yang. Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005; 75:276-81; PMID:15602723; http://dx.doi.org/10.1002/jmv.20267
20. J.H.Tsai, C.S.Hsu, C.H.Tsai, J.M.Su, Y.T.Liu, M.H.Cheng, J.C.Wei, F.L.Chen, C.C.Yang. Relationship between viral factors, axillary lymph node status and survival in breast cancer. J Cancer Res Clin Oncol 2007; 133:13-21; PMID:16865407; http://dx.doi.org/10.1007/s00432-006-0141-5
21. J.D.Khoury, N.M.Tannir, M.D.Williams, Y.Chen, H.Yao, J.Zhang, E.J.Thompson, TCGA Network, F.Meric-Bernstam, L.J.Medeiros, et al. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol 2013; 87:8916-26; PMID:23740984; http://dx.doi.org/10.1128/JVI.00340-13
22. A.-E.Al Moustafa,. E5 and E6/E7 of high-risk HPVs cooperate to enhance cancer progression through EMT initiation. Cell Adh Migr 2015; 9(5):392-3; http://dx.doi.org/10.1080/19336918.2015.1042197
23. D.Riethmuller, A.C.Jacquard, J.Lacau St Guily, F.Aubin, X.Carcopino, P.Pradat, A.Dahlab, J.L.Prétet. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France. BMC Public Health 2015; 15:453; PMID:25934423; http://dx.doi.org/10.1186/s12889-015-1779-1